Shi Chang Pu (Acorus)

What is Shi Chang Pu (Acorus)?

Shi Chang Pu (Acorus tatarinowii Schott) is the rhizome of a perennial, semi-aquatic plant native to China, Japan, and surrounding regions. It is one of the most frequently used herbs in classical Chinese neurological and psychiatric formulas, classified in TCM as pungent, warm, and aromatic, with a primary action of 'opening the orifices' and dissolving phlegm that clouds consciousness. The herb is listed in the Chinese Pharmacopoeia and remains a central ingredient in several modern standardized Chinese patent medicines targeting dementia, stroke-related cognitive impairment, and epilepsy.

How does Shi Chang Pu (Acorus) work?

The primary bioactive compounds, particularly beta-asarone and alpha-asarone, have been shown in preclinical research to modulate cholinergic neurotransmission (inhibiting acetylcholinesterase activity), upregulate BDNF and NGF signaling, attenuate neuroinflammation via NF-κB pathway suppression, and demonstrate GABAergic anxiolytic effects. These mechanisms collectively support its TCM actions of enhancing cognition, calming the spirit, and reducing excitatory neurological activity. It is important to note that while these mechanisms are well-characterized in animal models, direct human clinical mechanistic data remain limited.

What forms does Shi Chang Pu (Acorus) come in?

In traditional practice, the rhizome is decocted in water (3-9g dried herb per day). Modern standardized extracts are available in granule or capsule form, often as part of multi-herb formulas. Products sold in Western markets often use Acorus gramineus (a related species with lower asarone content) or are standardized to limit beta-asarone exposure. When selecting products, consumers should verify the species and asarone content to stay within established safety thresholds.

Where it comes from:

Shi Chang Pu has been documented in Chinese medical literature since the Shen Nong Ben Cao Jing (circa 200 CE), where it was classified as a superior herb for prolonging life, improving memory, and sharpening hearing and vision. Daoist practitioners historically used it in longevity formulas. Its use in formulas for stroke, dementia, and mental confusion is documented across the Jin Gui Yao Lue, Ben Cao Gang Mu, and numerous later classical texts, making it one of the longest-studied herbal cognitive agents in any medical tradition.

What does Shi Chang Pu (Acorus) help with?

• Cognitive Decline / Dementia: Shi Chang Pu-containing formulas have been evaluated in several Chinese clinical trials for Alzheimer's disease and mild cognitive impairment (MCI). The proposed mechanism involves beta-asarone-mediated acetylcholinesterase inhibition, BDNF upregulation, and reduction of amyloid-beta aggregation in preclinical models. A randomized controlled trial by Liao et al. (2014, Journal of Ethnopharmacology, n=60) evaluated a Shi Chang Pu-based formula (Kai Xin San) in MCI patients over 12 weeks and reported significant improvements in MMSE and MoCA scores compared to placebo, though the study was single-center and modest in size. Evidence is encouraging but requires replication in larger, multicenter trials.
• Vascular Cognitive Impairment: Multiple Chinese RCTs and systematic reviews have examined Acorus-containing formulas in post-stroke or vascular dementia populations. A systematic review by Zeng et al. (2015, Evidence-Based Complementary and Alternative Medicine) that analyzed several RCTs of Shi Chang Pu-containing formulas in vascular dementia found consistent improvements in MMSE scores and activities of daily living compared to conventional treatment alone, though the authors noted high heterogeneity and risk of bias across included studies. The proposed mechanism involves improved cerebral microcirculation and reduction of neuroinflammation. Clinical evidence quality is moderate; results should be interpreted cautiously.
• Anxiety and Mental Restlessness: Preclinical studies consistently demonstrate that alpha- and beta-asarone exert anxiolytic effects via potentiation of GABAergic signaling and modulation of the HPA axis stress response, producing effects comparable to benzodiazepines in rodent models without the same degree of motor impairment. Human RCT evidence specifically isolating Shi Chang Pu for anxiety is limited; most clinical data comes from multi-herb formulas (e.g., formulas combining with Yuan Zhi and Fu Shen) in TCM psychiatric practice. The clinical evidence base for anxiety as a standalone indication is currently insufficient to make strong efficacy claims independent of traditional use.
• Epilepsy (adjunctive support): Shi Chang Pu has a long classical history as an anti-epileptic herb in TCM. Beta-asarone has demonstrated anticonvulsant properties in multiple animal seizure models (PTZ, pilocarpine, maximal electroshock), with proposed mechanisms including sodium channel modulation and GABA-A receptor potentiation. A small Chinese clinical study by Liu et al. (reported in the Chinese Journal of Integrated Traditional and Western Medicine, 2010) examined an Acorus-containing formula as adjunctive therapy to conventional antiepileptics and reported reduced seizure frequency in refractory partial epilepsy, but the study was open-label with a small sample. This remains an area of interest without robust human trial data.
• Post-Stroke Neurological Recovery: Shi Chang Pu is a key ingredient in several patent Chinese medicines used in stroke rehabilitation, including formulas targeting aphasia, cognitive fog, and motor recovery. Its neuroprotective mechanisms include attenuation of glutamate excitotoxicity, reduction of oxidative stress, and anti-inflammatory effects on activated microglia. Clinical trials examining these formulas (most conducted in China, published in Chinese-language journals) report improvements in neurological deficit scores and cognitive outcomes, but trial quality is generally limited by lack of blinding, small samples, and short follow-up.
• Depression (mild to moderate, adjunctive): Some Chinese clinical research has explored Shi Chang Pu-containing formulas (particularly in combination with Bai He and Yu Jin) in mild-to-moderate depression, with proposed mechanisms involving monoamine modulation and HPA axis regulation. Preclinical data supports beta-asarone-mediated effects on serotonin and dopamine pathways. Human clinical evidence remains preliminary and largely confined to small open-label studies or as an adjunct to standard antidepressants; this indication should be considered exploratory until larger controlled trials are conducted.

What can Shi Chang Pu (Acorus) help prevent?

• Age-related cognitive decline (preliminary evidence from TCM clinical research; larger trials needed to confirm preventive benefit)

Which foods are rich in Shi Chang Pu (Acorus)?

Shi Chang Pu (Acorus tatarinowii) is not found in the food supply; it is an herbal rhizome used medicinally and not consumed as a dietary ingredient. However, several dietary patterns and specific foods support the same neurological and cognitive pathways that Shi Chang Pu targets. Foods rich in choline (eggs, liver, soybeans) support cholinergic neurotransmission, the same pathway Shi Chang Pu's beta-asarone modulates. Oily fish (salmon, sardines, mackerel) provide omega-3 fatty acids (especially DHA) that support BDNF signaling and neuronal membrane integrity. Blueberries, dark leafy greens, and other polyphenol-rich foods reduce neuroinflammation via overlapping anti-inflammatory pathways. Fermented foods (kimchi, kefir, miso) supporting gut-brain axis health are also increasingly implicated in cognitive and mood outcomes. A Mediterranean-style or MIND dietary pattern is the best-supported dietary framework for the cognitive and neuroprotective goals associated with Shi Chang Pu use.

What are the side effects of Shi Chang Pu (Acorus)?

• Nausea or gastrointestinal discomfort (most common at higher doses)
• Excessive salivation (reflecting cholinergic activity)
• Sedation or drowsiness (particularly in combination with other CNS depressants)
• Potential genotoxicity with long-term high-dose exposure to beta-asarone (regulatory concern, human data insufficient)
• Allergic skin reactions (rare, contact dermatitis reported with topical use of raw herb)
• Contraindicated in pregnancy due to potential emmenagogue and uterine-stimulating effects (traditional contraindication)

Good to know:

Shi Chang Pu is generally well tolerated at traditional TCM doses (3-9g dried rhizome daily) for short-term use. The most significant safety concern is the beta-asarone content, which has been classified as potentially genotoxic and carcinogenic based on rodent studies by EFSA and other regulatory bodies. The European Union restricts asarone in food flavorings; long-term high-dose use is discouraged pending further human safety data. Pregnant and breastfeeding women should avoid use due to insufficient safety data and traditional contraindication in pregnancy.

How much Shi Chang Pu (Acorus) should you take?

• Recommended daily: 3-9g dried rhizome per day in traditional decoction (Chinese Pharmacopoeia standard range). For standardized extracts, follow manufacturer specifications and ensure beta-asarone content is within regulatory limits (EFSA guidance: ≤0.1mg beta-asarone/kg body weight/day as a provisional threshold of concern). Many Western products use low-asarone Acorus gramineus varieties or asarone-depleted extracts.
• Best time of day: Traditionally administered in decoction divided across 2-3 doses throughout the day. Capsule or extract forms are often taken in the morning and early afternoon to leverage cognitive-enhancing effects during active hours; sedating effects may make evening dosing preferable for anxiety and sleep support.
• With or without food: Traditionally taken with food to minimize gastrointestinal discomfort. Taking with a meal is recommended for most forms.
• Time to effect: Acute effects (sedation, mental calming) may be noticeable within 1-4 hours. Cognitive and neurological benefits in clinical studies typically measured at 4-12 weeks of consistent use.
• How long to take it: TCM clinical protocols typically run 4-12 weeks for cognitive indications. Long-term continuous use at high doses is not recommended due to asarone safety concerns. Periodic breaks (e.g., 4 weeks on, 1-2 weeks off) are a practical precaution for sustained use. Consult a qualified TCM practitioner or integrative physician before extended use.